CXCL13 and metastatic colorectal cancer: In the study of metastatic colorectal cancer and endometrial cancer, CXCL13+CD8+T cells in tumor microenvironment (TME) have been shown to exhibit high proliferation ability, tumor-activating characterization and expression anti-tumor molecular capability, which can be a predictor of better prognosis (55, 56).